Mandatory notification of trade

13 Feb 2026 09:26 CET

Moss, 13 February 2026

Gentian Diagnostics ASA ("Gentian") has today been notified that the following
transaction has been completed by a primary insider in Gentian:

Matti Heinonen, Chief Executive Officer and primary insider in Gentian, has
purchased 2,500 shares in Gentian at NOK 40.00 per share. Mr. Heinonen owns
7,500 shares and 100,000 options after this transaction.


PDMR notification pursuant to the EU Market Abuse Regulation Article 19 is
attached.

This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act, EU Market Abuse Regulation Article
19 and Euronext Oslo Rule Book II.

For further information, please contact: Njaal Kind, Group CFO,
njaal.kind@gentian.no, +47 91 90 65 25

More information:
Access the news on Oslo Bors NewsWeb site

665812_2026 02 13 Heinonen KRT-1500.pdf